Moody National Bank Trust Division Increases Stake in Intuitive Surgical, Inc. $ISRG

Moody National Bank Trust Division increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,924 shares of the medical equipment provider’s stock after purchasing an additional 1,716 shares during the quarter. Moody National Bank Trust Division’s holdings in Intuitive Surgical were worth $2,409,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $1,335,753,000. J. Stern & Co. LLP increased its holdings in shares of Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after buying an additional 2,115,814 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the last quarter. Polen Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $477,225,000. Finally, Invesco Ltd. boosted its holdings in shares of Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 1,089 shares of Intuitive Surgical stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the transaction, the vice president owned 1,026 shares of the company’s stock, valued at $384,175.44. This trade represents a 51.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 over the last 90 days. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $1.72 during mid-day trading on Tuesday, reaching $404.76. 1,649,590 shares of the company were exchanged, compared to its average volume of 2,425,763. The business has a 50 day simple moving average of $381.62 and a two-hundred day simple moving average of $412.58. The stock has a market capitalization of $142.99 billion, a PE ratio of 46.36, a PEG ratio of 2.96 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.81 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Artificial intelligence could support Intuitive Surgical’s long-term growth by improving surgical planning, workflow efficiency and clinical data analysis. However, adoption, regulation and execution remain important uncertainties. 3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
• Positive Sentiment: A recent investment analysis argues that Intuitive’s valuation multiple has contracted while the underlying business story remains intact. The company’s earnings growth, recurring instrument and accessory revenue, and continued adoption of robotic-assisted surgery could provide support if procedure volumes accelerate. Intuitive Surgical: The Multiple Fell, The Story Didn’t
• Neutral Sentiment: The broader medical-instruments outlook places ISRG alongside Globus Medical and Thermo Fisher Scientific, highlighting artificial intelligence as a potential growth avenue while noting that industry conditions and regulatory developments will influence commercialization. Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
• Negative Sentiment: ISRG has decreased 8.2% over the past year, significantly underperforming the S&P 500. The stock’s valuation remains demanding at roughly 46 times earnings, and it trades below its 200-day moving average, leaving investors focused on whether new system placements, procedure growth and recurring revenue can justify a rebound. What Could Lift ISRG Stock?

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on ISRG shares. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research note on Thursday, July 30th. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Citigroup dropped their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Finally, Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Twenty-two analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $502.53.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.